The abstract is read at the publisher; the summary is JClub's.
ApoC1 is linked to hepatitis B virus (HBV) virions and filamentous subviral particles (fSVPs) and enhances HBV infectivity via SR-B1 in an HBV infection model.
- Why it matters: Antiviral drugs suppress HBV replication but seldom yield a functional cure, so mapping host factors on virions and fSVPs is needed to find new therapeutic targets.
- What they did: Highly purified HBV virions and fSVPs were profiled by mass spectrometry, followed by RNAi phenotypic testing in an HBV infection model; ApoC1 effects were assessed with cholesterol and HDL supplementation and SR-B1 inhibition.
- The result: ApoC1 depletion lowered intracellular cholesterol, reducing SVP production and infection, which exogenous cholesterol restored; ApoC1 also associated with particles and increased infectivity, while exogenous HDL boosted HBV and HDV infection and SR-B1 inhibition suppressed both.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.